You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

Not yet recruiting
  • Renal Cell Carcinoma
  • Sodium Pentaborate
  • Tabriz, East Azarbayejan, Iran, Islamic Republic of
    Imam Reza hospital and Clinic of Salamat
Mar 23, 2023

RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

Not yet recruiting
  • RCC
  • Renal Cell Carcinoma
  • Cabozantinib 80 MG
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2023

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • +2 more
  • CAR.70/IL15-transduced CB-derived NK cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

CaboCHECK - Cabozantinib in Adult Advanced Renal Cell Carcinoma

Terminated
  • Advanced Renal Cell Carcinoma (All Subtypes)
  • Metastatic Renal Cell Carcinoma (All Subtypes)
  • Documentation
  • Essen, Nordrhein-Westfalen, Germany
  • +1 more
Dec 21, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Among Advanced Renal Cell Carcinoma Receiving Systemic

Not yet recruiting
  • Carcinoma, Renal Cell
    • (no location specified)
    Sep 6, 2022

    Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

    Terminated
    Has Results
    • Renal Cell Carcinoma (RCC)
    • Chimeric monoclonal antibody cG250
    • Sunitinib malate
    • Heidelberg, Victoria, Australia
      Austin Health (Ludwig Institute Oncology Unit)
    Oct 3, 2022

    Smart-Phone App for Advanced Renal Cell Carcinoma Undergoing

    Recruiting
    • Renal Cell Carcinoma Stage IV
    • mHealth Smart Phone Application
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 11, 2022

    Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    Axitinib Dose Reduction and Interruption for Adverse Event

    Completed
    • Renal Cell Carcinoma
    • New York, New York
      Pfizer
    Sep 15, 2022

    Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

    Suspended
    • Metastatic Cancer
    • Renal Cancer
    • Indianapolis, Indiana
    • +3 more
    Oct 29, 2022

    Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

    Recruiting
    • Renal Cell Carcinoma
    • Macquarie University, New South Wales, Australia
    • +1 more
    Aug 15, 2022

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Kidney Cancer Trial in Houston (Axitinib)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 2, 2022

    Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)

    Not yet recruiting
    • Advanced Renal Cell Carcinoma
    • QL1706 Plus Lenvatinib
    • (no location specified)
    Feb 21, 2022

    Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +1 more
    Dec 14, 2022

    Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • IVAC
    • Heilbronn, Germany
      SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
    Nov 30, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Palo Alto (Doppler ultrasound, Long Ensemble Angular-coherence

    Recruiting
    • Renal Cell Carcinoma
    • Metastatic Renal Cell Carcinoma
    • Doppler ultrasound
    • +2 more
    • Palo Alto, California
      Stanford
    Mar 22, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    And Use Of Avelumab In Combination With Axitinib For Treatment

    Recruiting
    • Advanced Renal Cell Carcinoma
    • Sandwich, Kent, United Kingdom
      Pfizer Ltd
    May 23, 2022

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

    Recruiting
    • ccRCC
    • +9 more
    • Oral NKT2152
    • Scottsdale, Arizona
    • +6 more
    Oct 17, 2022

    Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

    Recruiting
    • Renal Cell Carcinoma
    • donor FMT
    • Placebo FMT
    • Rome, Italy
    • +1 more
    Jul 26, 2022